Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered platforms for mimicking cardiac development and drug screening

Cellular and Molecular Life Sciences(2024)10.1007/s00018-024-05231-1Source: DataRank Database

Engineered platforms for mimicking cardiac development and drug screening is a research paper published in Cellular and Molecular Life Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.17)OA: goldTopics (62)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Haokang Zhang ORCID,Leo Q. Wan ORCID,Madison R. Stiefbold ORCID

Live enrichment

PubMed:38664263 PMC:PMC11045633 OpenAlex:https://openalex.org/W4395445626

National Heart, Lung, and Blood Institute

Grant: R01 HL148104

National Institute of General Medical Sciences

Grant: R01 GM141387

National Institutes of Health

Grant: 5R01GM141387-03

Understanding Chirality at Cell-Cell Junctions With Microscale Platforms

National Institutes of Health

Grant: 1R01HL148104-01A1

Understanding Cardiac C-Looping Using Microscale In Vitro Models

FWCI

4.17

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://link.springer.com/content/pdf/10.1007/s00018-024-05231-1.pdf

HYBRIDhttps://doi.org/10.1007/s00018-024-05231-1

publisherhttps://link.springer.com/content/pdf/10.1007/s00018-024-05231-1.pdf

publisherhttps://link.springer.com/article/10.1007/s00018-024-05231-1/fulltext.html

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38664263

Fields of Study

Tissue Engineering and Regenerative Medicine3D Printing in Biomedical ResearchPluripotent Stem Cells ResearchMedicineEngineering0301 basic medicine0303 health sciences03 medical and health sciencesHumansAnimalsDrug Evaluation, PreclinicalHeartTissue EngineeringOrganoidsPluripotent Stem CellsHeart Defects, CongenitalLab-On-A-Chip Devices

MeSH Terms

AnimalsDrug Evaluation, PreclinicalHeartHeart Defects, CongenitalHumansOrganoidsTissue EngineeringPluripotent Stem CellsLab-On-A-Chip Devices

Keywords

Induced pluripotent stem cellDrug discoveryComputational biologyDrug developmentOrgan-on-a-chipGenome editingBiologyHeart developmentComputer scienceMicrofluidicsNanotechnologyNeuroscienceBiotechnologyBioinformaticsEmbryonic stem cellCRISPRDrugGeneticsPharmacologyCardiac developmentCongenital Heart DiseasesCardiac Tissue EngineeringCardiac MorphogenesisOrgan-on-chipIn Vitro PlatformsEmbryo-on-chipOrganoidsPluripotent Stem CellsHeart Defects, CongenitalTissue EngineeringLab-On-A-Chip DevicesDrug Evaluation, PreclinicalHumansAnimalsHeartReview

Sustainable Development Goals

SDG 0: Industry, innovation and infrastructure